维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Argiles A"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	血液透析患者血压水平的地域和季节性差异显示文摘季节和气候对一般人群以及血液透析患者的血压调节有影响。目前这个现象在世界各地是否有所不同尚不清楚。研究者对来自7个欧洲国家(西班牙、意大利、法国、比利时、德国、英国和瑞典)2005-2011年间参加国际透析预后与实践模式研究(dialysis outcomes and practice patterns study,DOPPS)的患者进行了研究,目的是探究来自不同地理位置的血液透析患者的血压季节差异。	刘青叶鹏 Duranton F Kramer A Szwarc I Bieber B Gayrard N Jover B Vetromile F Massy ZA Combe C Tentori F Jager KJ Servel MF Argilés 	2018	中华高血压杂志2018，26，1：	5
2	Review on uremic toxins:classification,concentration,and interindividual varia-bility显示文摘	Vanholder R De Smet R Glorieux G Argiles A Baur-meister U? Brunet P	2003	Kidney Int2003，63，：	1
3	Creatine kinitie modeling:a simple and reliable tool for the assessment of protein nutritional status in hemodialysis patients显示文摘	Canaud B Garred IJ Argiles A	1995	Nephrol-Dial-Transplant1995，10，：	1
4	Seasonal modifications in blood pressure are mainly related to interdialytic body weight gain in dialysis patients显示文摘	Argiles A Lorho R Servel MF	2004	Kidney Int2004，65，：	1
5	Directeffects of doxorubicin on skeletal muscle contribute to fatigue显示文摘	Van Norren K Van Helvoort A Argiles J M	2009	Brit J Cancer2009，100，6：	1
6	Chronic kidney disease as cause of cardiovascular morbidity and mortality 显示文摘	Vanholder R Massy Z Argiles A	2005	Nephrol Dial Transplant2005，20，6：	1
7	Chronic kidney disease as cause of cardiovascular morbidity and mortality 显示文摘	VANHOLDER R MASSY Z ARGILES A	2005	Nephrol Dial Transpl2005，20，6：	1
8	A new look at an old drugfor the treatment of cancer cachexia: megestrol acetate显示文摘	Argil^s jM Anguera A Stemmier B	2013	ClinNutr2013，32，3：	1
9	Rousseau solution and absorption properties of hydrophobic associating water-soluble polyacrylamide显示文摘	Argiller J F Audibert A Lecourtier J	1996	Colloids and Surfaces A:Physicochemical and Engineering Aspects1996，113，：	1
10	Chronic kid-ney disease as cause of cardiovascular morbidity andmortality显示文摘	Vanholder R Massy Z Argiles A el al	2005	Nephrol Dial Transplant2005，20，6：	1
11	Chronic kidney disease as cause of cardiovascular morbidity and mortality 显示文摘	Vanholder R Massy Z Argiles A	2005	Nephrol Dial Transplant2005，20，6：	1
12	Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease显示文摘	Good D M Zuerbig P Argiles A	2010	Mol Cell Proteomics2010，9，11：	1
13	Seasonal changes in blood pressure in patients with end-stage renal disease treated with hemodialysis 显示文摘	Argiles A Mourad G Mion C	1998	N Engl J Med1998，339，：	1
14	Chronic kidneydisease as cause of cardiovascular morbidity and mortality显示文摘	Vanholder R Massy Z Argiles A	2005	Nephrol Dial Transplant2005，20，：	1
15	How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism?显示文摘	Argile's A Mourad G	1998	Nephrol Dial Transpl1998，133，：	1
16	Dialysis-related amyloidosis:visceral involvement and protein constituents显示文摘	Campistol JM Argiles A	1996	Nephrol Dial Transplant1996，11，3：	1
17	Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia 显示文摘	Argiles J M Busquets S Felipe A	2005	Int J Biochem Cell Biol2005，37，5：	1
18	Post-conditioning to reduce renal ischaemia/reperfusion injury显示文摘	Szwarc I Mourad G Argiles A	2009	Nephrol Dial Transplant2009，24，7：	1
19	The general picture of uremia显示文摘	Almeras C Argiles A	2009	Semin Dial2009，，4：	1
20	Calcium balance and intact PTH variations during haemodiafil tration显示文摘	Argiles A Mion CM	1995	Nephrol Dial Transplant1995，，1995：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示